SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Lidak Pharm. [LDAKA]
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: joco who wrote (205)5/16/1997 12:57:00 AM
From: John Zwiener   of 1115
 
According to Henry Nimann on the Ligand thread, the usualhistory of Kaposi's lesions is that 10% regress on their own.http://www.techstocks.com/~wsapi/investor/s-8060/reply-2871

But note that a time line is not given. Also, although Henry is relatively accurate in his posts, he does not always have a clinical perspective that is as accurate, still he is good. At least this gives a little more evidence that lidakol may be a good drug. I'll try to find out what should be the usual natural course of the lesions over the equivilent time frame that lidaks trial took place. This company seems cheap compared to it's potential and compared to other companies. Of course, who knows? Katz does I think. Some have said he has sold some stock, but I still can't find it. Would someone post where I can find what you are saying?

Also, off subject, Ligand seems dirt cheap.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News